Consynance Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11 University Pl Ste D210b, Rensselaer, ...Phone Number
(518) 275-0176Website
www.consynance.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Consynance Therapeutics
Consynance Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for rare central nervous system disorders, particularly Prader-Willi Syndrome. The company aims to address neuropsychiatric conditions related to neurotransmitter dysregulation, specifically targeting behavioral dysregulation and hyperphagia. Their lead product, CSTI-500, is a tunable triple monoamine reuptake inhibitor designed to meet the high unmet needs of patients. Consynance Therapeutics is dedicated to transforming scientific discoveries into life-changing treatments for affected individuals.Explore more
Consynance Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Consynance Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Consynance Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Consynance Therapeutics is spiking on competitors!
Earning: See what the market has to say on Consynance Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Consynance Therapeutics
Check if Consynance Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Consynance Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Consynance Therapeutics launches new products
Click to see if Consynance Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Consynance Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Consynance Therapeutics
Compare insights from companies similar to Consynance Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Consynance Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Consynance Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Consynance Therapeutics.
Consynance Therapeutics Tech Stack
A closer look at the technologies used by Consynance Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Consynance Therapeutics
Sign Up For FreeTo access detailed company insights
Consynance Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for rare central nervous system disorders, particularly Prader-Willi Syndrome. The company aims to address neuropsychiatric conditions related to neurotransmitter dysregulation, specifically targeting behavioral dysregulation and hyperph... Read More
